Investigational Site Number 616016
Lubin 59-301
0 studies enrolling now · 1 studies all time
What they study most
Atherosclerotic Cardiovascular Disease
Studies at this site
ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
— Completed